These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. What is the value of repeat kidney biopsies in patients with lupus nephritis? Morales E, Trujillo H, Bada T, Alonso M, Gutiérrez E, Rodríguez E, Gutiérrez E, Galindo M, Praga M. Lupus; 2021 Jan; 30(1):25-34. PubMed ID: 33081588 [Abstract] [Full Text] [Related]
5. The prognosis and pathogenesis of severe lupus glomerulonephritis. Schwartz MM, Korbet SM, Lewis EJ, Collaborative Study Group. Nephrol Dial Transplant; 2008 Apr; 23(4):1298-306. PubMed ID: 18045825 [Abstract] [Full Text] [Related]
6. Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy. Pagni F, Galimberti S, Galbiati E, Rebora P, Pietropaolo V, Pieruzzi F, Smith AJ, Ferrario F. Nephrology (Carlton); 2016 Jan; 21(1):35-45. PubMed ID: 26132414 [Abstract] [Full Text] [Related]
10. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, Qu Z, Chen MH, Gao JJ, Li ZY, Zheng X, Ao J, Zhu SN, Wang SX, Zhao MH, Zou WZ, Liu G. Kidney Int; 2010 May; 77(9):820-9. PubMed ID: 20182417 [Abstract] [Full Text] [Related]
12. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshima A, Kaneko Y, Hiromura K, Ueki K, Nojima Y. Rheumatology (Oxford); 2008 May; 47(5):702-7. PubMed ID: 18390590 [Abstract] [Full Text] [Related]
16. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Hill GS, Delahousse M, Nochy D, Rémy P, Mignon F, Méry JP, Bariéty J. Kidney Int; 2001 Jan; 59(1):304-16. PubMed ID: 11135084 [Abstract] [Full Text] [Related]
17. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN. Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851 [Abstract] [Full Text] [Related]
18. Association of explanatory histological findings and urinary protein and serum creatinine levels at renal biopsy in lupus nephritis: a cross-sectional study. Katsuyama E, Miyawaki Y, Sada KE, Asano Y, Hayashi K, Yamamura Y, Hiramatsu-Asano S, Morishita M, Ohashi K, Watanabe H, Katsuyama T, Narazaki M, Matsumoto Y, Wada J. BMC Nephrol; 2020 Jun 01; 21(1):208. PubMed ID: 32487161 [Abstract] [Full Text] [Related]
19. Revised ISN/RPS 2018 classification of lupus renal pathology predict clinical remission. Krassanairawiwong K, Charoenpitakchai M, Supasyndh O, Satirapoj B. Int Urol Nephrol; 2021 Jul 01; 53(7):1391-1398. PubMed ID: 33682052 [Abstract] [Full Text] [Related]
20. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures. Wakasugi D, Gono T, Kawaguchi Y, Hara M, Koseki Y, Katsumata Y, Hanaoka M, Yamanaka H. J Rheumatol; 2012 Jan 01; 39(1):79-85. PubMed ID: 22089455 [Abstract] [Full Text] [Related] Page: [Next] [New Search]